Leading by example

Board of Directors

Chairman & Managing Director
Glenn Saldanha
Chairman & Managing DirectorGlenn Saldanha

Mr. Glenn Saldanha is the Chairman & Managing Director of Glenmark Pharmaceuticals Ltd. He joined in 1998 as Director and took over as Managing Director & CEO in 2001.

As Chairman & Managing Director of the Company, Mr. Saldanha oversees all operations of the organization. During his tenure, he transformed Glenmark into a truly global organization with revenue over a billion dollar and commercial presence in over 80 countries. Under his leadership, Glenmark has evolved from an Indian branded generics business, into a research-driven and innovation-led organization. Mr. Saldanha’s vision is to discover, develop and take to market India's first innovative drug for the entire world.

Mr. Saldanha holds a bachelor’s degree in pharmacy from Mumbai University and is an MBA from the Leonard Stern School of Business at New York University. Prior to Glenmark, he has worked with Eli Lily, USA and PriceWater House Coopers, USA.

Executive Director – Corporate Services
Cherylann Pinto
Executive Director – Corporate ServicesCherylann Pinto

Ms. Cherylann Pinto is an executive member of the Board of Directors and is one of the promoters of Glenmark Pharmaceuticals Ltd. She has over 30 years of pharma industry experience and has been associated with Glenmark since 1999. As Executive Director – Corporate Services, she heads Glenmark’s Human Resources, Corporate Communications, Corporate Social Responsibility, Information Technology, Administration and Insurance functions. Prior to her association with Glenmark, Ms. Pinto had founded a pharmaceutical company where she was the Managing Director for 10 years.

Glenmark’s CSR initiatives under her leadership have been recognized by the Bombay Chambers of Commerce Award 2014 for the contribution in the area of Child Health, reducing malnutrition & infant mortality, improving medicine access and providing sustainable livelihood. Ms. Pinto has received the ‘Women Leadership Award’ at the CMO Asia’s 5th Best CSR Practices Award in 2015 and was also acknowledged as one of the 100 Most Impactful CSR Leaders Globally by the World CSR Congress in 2017.

Ms. Pinto holds a Bachelor’s Degree in pharmacy from the Institute of Chemical Technology (ICT) in Mumbai and has also completed The General Management Program from the Harvard Business School in Boston.

Executive Director and Global Chief Financial Officer
Mr. V. S. Mani
Executive Director and Global Chief Financial OfficerMr. V. S. Mani

Mr. V. S. Mani is an executive member of the Board of Directors and is also the Global Chief Financial Officer of Glenmark Pharmaceuticals Ltd. He is responsible for the company’s worldwide finance operations and secretarial function, including global accounting, financial reporting, tax and treasury. He has over 25 years of rich industry experience across treasury, taxation (direct, indirect & international), accounting, financial planning & analysis, secretarial, legal, audits (internal & statutory), risk management and investor relations.

Prior to joining Glenmark in 2017, he was the President Finance at the Bhartiya Group. He has also held the position of the Chief Financial Officer at Cipla and played a key role in acquisition of various companies in emerging and mature markets for the organization. He is a qualified Chartered Accountant.

Non-Executive Director
Rajesh V Desai
Non-Executive DirectorRajesh V Desai

Mr. Rajesh V. Desai is a Non-Executive Director at Glenmark Pharmaceuticals Limited. Mr. Desai has over 34 years of work experience. He was the Chief Financial Officer of Glenmark till 2016. He led the Finance, Legal & IT functions and with his strong Finance background, he contributed significantly to the growth story of Glenmark.

Mr. Desai holds a Bachelors Degree in Science (B.Sc.) from the Bombay University and is a Chartered Accountant from Institute of Chartered Accountants of India (ICAI).

Non-Executive Director
Saira Ramasastry
Non-Executive DirectorSaira Ramasastry

Ms. Saira Ramasastry has over 20 years of experience in life sciences industry successfully building companies as an advisor, board member and operational executive. She is the Founder & Managing Partner of Life Sciences Advisory, LLC and is also associated with the European Prevention of Alzheimer’s Dementia (EPAD) as head of Business & Sustainability where she is currently leading processes to create $50 million public private consortium focused on Alzheimer’s Dementia (AD) prevention. She is also a Strategic Advisor to G8 Health Initiatives and is the Co-Founder and President of the For Life Institute. She serves on the Industry Advisory Board of the Michael J. Fox Foundation for Parkinson’s Research and the Advisory Council for Judge School of Business at the University of Cambridge. She is also a Health Innovator Fellow of the Aspen Institute.

Ms. Ramasastry accomplishments include being named as top life sciences advisor by Acquisition International and CorporateLiveWire. Her past experiences include leading emerging biotechnology investment banking coverage for Merrill Lynch for over a decade and as a healthcare M&A analyst at Wasserstein Perella.  

Ms. Ramasastry is B.A. in Economics with Honors and Distinction and an M.S. in Management Science and Engineering from Stanford University where she graduated Phi Beta Kappa. She also holds M.Phil. in Management Studies from the University of Cambridge.

Non-Executive Director
Brian W Tempest
Non-Executive DirectorBrian W Tempest

Dr. Brian W. Tempest is the Editor of the Journal of Generic Medicines. He is also a Non-Executive Director on the Governance Board of the United Nations Patent Pool. Previously he worked for Ranbaxy Laboratories since 1995 holding the position of Managing Director and Chief Executive Officer until 2005. He was then Chief Mentor and Non-Executive Director until 2008.

Dr. Tempest has also worked for Glaxo as Regional Director Far East and Regional Director Middle East & Africa from 1985 to 1992. He has worked in the Pharmaceutical Industry for the last 45 years and has managed Healthcare businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India.

Dr. Tempest is now a Non-Executive Director of Petainer-Innopac. He is a member of the SCRIP Global awards panel. He is also an international advisor to UNCTAD and MAPE, an Indian M&A boutique. Dr. Tempest has a PhD in Polymer Chemistry from Lancaster University and a D.Sc. (Hon) from Aston University, UK. In 2009 he became Chairman of the Advisory Board for the Lancaster University Management School, UK. He is a Fellow of the Royal Society of Medicine, a Fellow of the Royal Society of Chemistry and is a Chartered Chemist.

Non-Executive Director
Bernard Munos
Non-Executive DirectorBernard Munos

Mr.Bernard Munos is a Senior Fellow at FasterCures, a center of the Milken Institute. His research on pharmaceutical innovation has been published in Nature and Science, as well as profiled by Forbes magazine. The popular industry newsletter FiercePharma has named him one of the 25 most influential people in biopharma. 

Mr. Munos advises organizations on being better innovators. He serves on the Advisory Council of the National Center for Advancing Translational Sciences (NCATS); is a member of the National Academy of Medicine's Forum on Drug R&D and Translation; an Advisor to the journal Science Translational Medicine; and an Advisor to or Board member of multiple companies and publicly-financed research organizations.

Mr. Munos has discussed his research at numerous meetings sponsored by the President's Cancer Panel, the NIH Leadership Forum, the FDA, the World Health Organization, the OECD, the New York Academy of Sciences, the Brookings Institution, the Kauffman Foundation, the US Patent and Trademark Office, the American Chemical Society, as well as leading universities in the US, Europe, and Asia. He also blogs about innovation for Forbes and FastCures.

Mr. Munos received his MBA from Stanford University, and holds other graduate degrees from University of California at Davis, and the Paris Institute of Technology for Life, Food and Environmental Sciences in France. 

Non-Executive Director
Blanche E. Saldanha
Non-Executive DirectorBlanche E. Saldanha

Mrs. Blanche E. Saldanha is a Non-Executive Director and a member of the promoter group of Glenmark Pharmaceuticals Limited. Prior to this position, Mrs. Saldanha was the Director – Exports and managed Glenmark’s international operations from 1982 to 2005. During her 23 year tenure with the organization, she was responsible for developing and growing the company’s export business.

Mrs. Saldanha holds a Bachelors Degree in Science (B.Sc.) and a Bachelors Degree in Education (B.Ed.) from Bombay University.

Non-Executive Director
Julio Ribeiro
Non-Executive DirectorJulio Ribeiro

Mr. Julio Ribeiro has been associated with Glenmark since 1999. He is a retired Indian police officer & civil servant and has held increasingly responsible positions during his career. Some of the noteworthy positions include - the Commissioner of Police, Mumbai; Special Secretary to Government of India, Ministry of Home Affairs; Director General of Police, Punjab; Adviser to the Governor of Punjab and Ambassador of India to Romania.

Mr. Ribeiro was conferred with the Padma Bhushan, India's third highest civilian award for his services in 1987. He served as an Independent Director of Fullerton India Credit Company Limited until 2011 and currently serves as Director of VVF Ltd. Mr. Ribeiro holds a Bachelors degree in Commerce and a Bachelors degree in Law from the Bombay University.

Non-Executive Director
Sridhar Gorthi
Non-Executive DirectorSridhar Gorthi

Mr. Sridhar Gorthi is a partner in the Mumbai office of Trilegal and his areas of expertise include M&A, joint ventures, private equity and venture capital. He has been actively involved in several high profile cross-border transactions and is a leading member of Trilegal's corporate practice. Apart from representing a number of international clients on M&A in India, Mr. Gorthi has also advised Indian companies in connection with outbound M&A transactions in jurisdictions such as the UK, USA, South Africa, Argentina, Indonesia and Sri Lanka.

Mr. Gorthi has been named one of the leading lawyers in India for Mergers & Acquisitions, Private Equity and Venture Capital in India by the Guide to Asia Pacific’s Leading Lawyers 2010, 2011 and 2012; and by IFLR 1000, 2011 and 2012.

Non-Executive Director
Milind Sarwate
Non-Executive DirectorMilind Sarwate

Mr. Milind Sarwate is the Founder and CEO of Increate Value Advisors LLP, a firm that facilitates organizations and individuals to discover, develop and deliver business & social value. He has over 32 years of experience in Finance, HR and Strategy in groups like Marico & Godrej.

Mr. Sarwate has received the ICAI Award - CFO - FMCG 2011, CNBC TV-18 Best Performing CFO Award -FMCG & Retail-2012 and was also included in the CFO India Hall of Fame 2013 by CFO India magazine. 

He is a Chartered Accountant, Cost Accountant & Company Secretary, holds a Bachelors degree in Commerce (B.Com Hons.) from the Bombay University and a CII-Fulbright Fellow (Carnegie Mellon University, Pittsburgh, PA, USA).

Non-Executive Director
D R Mehta
Non-Executive DirectorD R Mehta

Mr. D.R. Mehta joined the Indian Administrative Service in 1961 and held numerous important positions initially in the Government of Rajasthan and later in the Government of India. He has served as Chairman of SEBI, the Deputy Governor of the RBI, the Director General of Foreign Trade, Ministry of Commerce and Government of India. He was also the Controller of Capital Issues, Additional Secretary Banking in the Ministry of Finance in Government of India.  

Mr. Mehta is the founder and chief patron of Bhagwan Mahaveer Viklang Sahayata Samiti (BMVSS) Jaipur, the world's largest organization for the rehabilitation of the handicapped. He was conferred with the Padma Bhushan in 2008 and the Rajiv Gandhi National Sadbhavana Award in 2012. Mr. Mehta holds a Bachelors Degree in Arts and an LLB degree from the Rajasthan University. He also holds Management Degrees from Royal Institute of Public Administration, London and Alfred Sloan School of Management, MIT, Boston, US.

Founder Emeritus

Late Mr. Gracias Saldanha

"Glenmark has been built on the pillars of Integrity, Knowledge, Trust & Respect"